money token crypto Top Knowledge

New Oriental acquired Taimei International Travel Service. Tianyancha App shows that recently, Taimei (Beijing) International Travel Service Co., Ltd. has undergone industrial and commercial changes, and Tianjin Vision Contemporary Technology Co., Ltd., the original wholly-owned shareholder, has withdrawn, and Beijing New Oriental Wokaide International Education Travel Co., Ltd. has been added as a shareholder and wholly owned. At the same time, the legal representative and several key personnel have changed. Taimei (Beijing) International Travel Service Co., Ltd. was established in May 2016. Its legal representative is Longhua with a registered capital of RMB 5 million. Its business scope covers domestic tourism business, inbound tourism business, outbound tourism business, exhibition activities, conference services, ticketing agents and air ticket sales agents.Actually, Zhijia has set up a new company to sell new energy vehicles. The enterprise search APP shows that recently, Beijing Dongwo Retail Co., Ltd. was established, with the legal representative of Li Jie and the registered capital of 10 million yuan. Its business scope includes: automobile sales; New energy vehicle sales; Wholesale of auto parts; Sales of electrical accessories for new energy vehicles; Sales of power exchange facilities for new energy vehicles. Enterprise investigation shows that the company is indirectly wholly-owned by Juran Zhijia.China Seismological Network officially determined that an earthquake of magnitude 5.2 occurred in Fiji Islands (14.95 degrees south latitude and 178.15 degrees west longitude) at 09: 51 on December 12, with a focal depth of 10 kilometers.

The British authorities confiscated 110 million yuan of assets of Hongtong criminal Tian Wenjun, and the British authorities confiscated 110 million yuan of assets of Hongtong criminal Tian Wenjun. On December 10, the National Bureau for Combating Crime (NCA) of the United Kingdom issued an announcement, officially confiscating 12 million pounds (about 110 million yuan) of assets of China citizens Tian Wenjun and Hao Jiangbo in the United Kingdom, including two luxury houses in the suburbs of hampstead, London, two student apartments in Coventry and funds in several bank accounts. However, these assets account for less than 1% of the officially recognized crime proceeds of the Tian couple in China. NCA formally filed a case with the Queen's Bench Court of the British High Court on November 26th, and applied for approval of the civil recovery orders against Tian Wenjun and Hao Jiangbo. This means that the loan fraudsters Tian and his wife, who are wanted by the China police and have absconded in the UK for five years, need not be convicted, and their unexplained assets in the UK will be confiscated. (Caixin. com)The ethylene plant of ExxonMobil Huizhou Ethylene Phase I Project entered the commissioning stage, and ExxonMobil China announced that in December 2024, the 1.6 million tons ethylene plant of ExxonMobil Huizhou Ethylene Phase I Project was handed over to China and entered the commissioning stage in an all-round way. ExxonMobil Huizhou Ethylene Project is located in Huizhou Daya Bay Petrochemical Park. The first phase of the project mainly includes ethylene plants, high-end polyethylene and polypropylene production plants in the middle and lower reaches, and supporting utilities, docks, storage and transportation and environmental protection facilities.Green debt base continues to attract gold! Since the beginning of this year, the issuance scale has approached 44 billion yuan. On December 12th, HSBC Jintrust Fund announced that HSBC Jintrust Green Bond Fund was formally established, with the initial raising scale of 5.98 billion yuan. In the first half of this year, the public offering market has issued four green debt bases-Manulife China Bond Green inclusive finance Preferred Index, Oriental China Bond Green Inclusive Theme Financial Preferred Index, Guofu China Bond Green inclusive finance Index and Jiashi China Bond Green Inclusive Theme Financial Preferred Index. Wind data shows that the total issuance scale of these four products reached 31.963 billion yuan, which set off a small climax of debt-based issuance at that time. So far, the issuance scale of green debt base has approached 44 billion yuan during the year. It can be expected that more green debt bases will meet with investors in the future. (CSI Taurus)

The Chinese medicine sector collectively pulled up Panlong Pharmaceutical's linear daily limit, Panlong Pharmaceutical's linear daily limit, Xiangxue Pharmaceutical, Kunyao Group, Huasen Pharmaceutical, Jingxin Pharmaceutical, Xinguang Pharmaceutical and Changyao Holdings followed suit.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.